Cell-specific blood-brain barrier regulation in health and disease: A focus on hypoxia

British Journal of Pharmacology

Volumn 171, Issue 5, 2014, Pages 1210-1230

  Engelhardt, S ^a   Patkar, S ^a   Ogunshola, O O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

astrocytes; BBB cell specific response; endothelial cells; HIF 1; hypoxia; neurodegenerative diseases; pericytes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AQUAPORIN 4; CHEMOKINE; GELATINASE A; GELATINASE B; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; PROLYL HYDROXYLASE INHIBITOR; STROMELYSIN; TIGHT JUNCTION PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ALZHEIMER DISEASE; ASTROCYTE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL FUNCTION; CELL INTERACTION; CELLULAR STRESS RESPONSE; CEREBROVASCULAR ACCIDENT; CYTOARCHITECTURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG TARGETING; ENDOTHELIUM CELL; ENERGY CONSUMPTION; HUMAN; NEUROANATOMY; NEUROMODULATION; OXYGENATION; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TIGHT JUNCTION; TRAUMATIC BRAIN INJURY;

ASTROCYTES; BBB CELL-SPECIFIC RESPONSE; ENDOTHELIAL CELLS; HIF-1; HYPOXIA; NEURODEGENERATIVE DISEASES; PERICYTES;

ANIMALS; ANOXIA; ASTROCYTES; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; PERICYTES;

EID: 84895190755     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12489     Document Type: Review

References (261)

1. Abbott NJ, (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 629-638.
2. Abbott NJ, Ronnback L, Hansson E, (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53.
3. Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ, (2010). Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25.
4. Abbruscato TJ, Davis TP, (1999a). Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. J Pharmacol Exp Ther 289: 668-675.
5. Abbruscato TJ, Davis TP, (1999b). Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact. Brain Res 842: 277-286.
6. Abumiya T, Lucero J, Heo JH, Tagaya M, Koziol JA, Copeland BR, et al. (1999). Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. J Cereb Blood Flow Metab 19: 1038-1050.
7. Al Ahmad A, Gassmann M, Ogunshola OO, (2009). Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation. J Cell Physiol 218: 612-622.
8. Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO, (2011). Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab 31: 693-705.
9. Allen NJ, Barres BA, (2009). Neuroscience: glia -more than just brain glue. Nature 457: 675-677.
10. Aminova LR, Siddiq A, Ratan RR, (2008). Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. Antioxid Redox Signal 10: 1989-1998.
11. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA, (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A 86: 4544-4548.
12. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al. (2006). IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177: 5574-5584.
13. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, et al. (2012). Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122: 2454-2468.
14. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468: 557-561.
15. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21: 7724-7732.
16. Baeten KM, Akassoglou K, (2011). Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol 71: 1018-1039.
17. Ballabh P, Braun A, Nedergaard M, (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16: 1-13.
18. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C, (1990). A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haem. J Neurol Neurosurg Psychiatry 53: 16-22.
19. Ban HS, Uto Y, Nakamura H, (2011). Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004-2010). Expert Opin Ther Pat 21: 131-146.
20. Bao Y, Bramlett HM, Atkins CM, Truettner JS, Lotocki G, Alonso OF, et al. (2011). Post-traumatic seizures exacerbate histopathological damage after fluid-percussion brain injury. J Neurotrauma 28: 35-42.
21. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC, (2007). Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27: 6320-6332.
22. Başkaya MK, Rao AM, Doǧan A, Donaldson D, Dempsey RJ, (1997). The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci Lett 226: 33-36.
23. Bauer AT, Burgers HF, Rabie T, Marti HH, (2010). Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30: 837-848.
24. Baumann E, Preston E, Slinn J, Stanimirovic D, (2009). Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia. Brain Res 1269: 185-197.
25. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. (2010). Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
26. Berezowski V, Landry C, Dehouck MP, Cecchelli R, Fenart L, (2004). Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier. Brain Res 1018: 1-9.
27. Bermpohl D, You Z, Lo EH, Kim H-H, Whalen MJ, (2007). TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab 27: 1806-1818.
28. Bouras C, Kövari E, Herrmann FR, Rivara C-B, Bailey TL, Gunten AV, et al. (2006). Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol 65: 235-244.
29. Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR, Davis TP, (2003). Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci 116: 693-700.
30. Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, et al. (1999). VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104: 1613-1620.
31. Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, et al. (2005). Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 166: 1883-1894.
32. Candelario-Jalil E, Yang Y, Rosenberg GA, (2009). Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158: 983-994.
33. Ceruti S, Colombo L, Magni G, Viganò F, Boccazzi M, Deli MA, et al. (2011). Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem Int 59: 259-271.
34. Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, et al. (2009). Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 33: 509-517.
35. Chen W, Jadhav V, Tang J, Zhang JH, (2008a). HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury. Acta Neurochir Suppl 102: 395-399.
36. Chen W, Jadhav V, Tang J, Zhang JH, (2008b). HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 31: 433-441.
37. Chi OZ, Hunter C, Liu X, Weiss HR, (2007). Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp Neurol 204: 283-287.
38. Chi OZ, Hunter C, Liu X, Weiss HR, (2008). Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia. Neurol Res 30: 288-293.
39. Choi HJ, Song B-J, Gong Y-D, Gwak WJ, Soh Y, (2008). Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2. Br J Pharmacol 154: 114-125.
40. Chow J, Ogunshola O, Fan SY, Li Y, Ment LR, Madri JA, (2001). Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res Dev Brain Res 130: 123-132.
41. Cipolla MJ, Crete R, Vitullo L, Rix RD, (2004). Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci 9: 777-785.
42. Claudio L, (1996). Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol 91: 6-14.
43. Colgan OC, Collins NT, Ferguson G, Murphy RP, Birney YA, Cahill PA, et al. (2008). Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function. Brain Res 1193: 84-92.
44. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T, (1999). IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol 101: 211-221.
45. Cui J, Chen S, Zhang C, Meng F, Wu W, Hu R, et al. (2012). Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener 7: 21.
46. Cunningham LA, Wetzel M, Rosenberg GA, (2005). Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50: 329-339.
47. Daneman R, Zhou L, Kebede AA, Barres BA, (2010). Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468: 562-566.
48. Davson H, Oldendorf WH, (1967). Symposium on membrane transport. Transport in the central nervous system. Proc R Soc Med 60: 326-329.
49. Deane R, Yan SD, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. (2003). RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913.
50. Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R, (1990). An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 54: 1798-1801.
51. Del Valle J, Duran-Vilaregut J, Manich G, Camins A, Pallàs M, Vilaplana J, et al. (2009). Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice. Int J Dev Neurosci 27: 47-52.
52. Deli MA, Abraham CS, Kataoka Y, Niwa M, (2005). Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25: 59-127.
53. Dirnagl U, Iadecola C, Moskowitz MA, (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
54. Dohgu S, Yamauchi A, Takata F, Naito M, Tsuruo T, Higuchi S, et al. (2004). Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol 24: 491-497.
55. Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M, et al. (2005). Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res 1038: 208-215.
56. Dore-Duffy P, Owen C, Balabanov R, Murphy S, Beaumont T, Rafols JA, (2000). Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 60: 55-69.
57. Dore-Duffy P, Wang X, Mehedi A, Kreipke CW, Rafols JA, (2007). Differential expression of capillary VEGF isoforms following traumatic brain injury. Neurol Res 29: 395-403.
58. Dore-Duffy P, Wang S, Mehedi A, Katyshev V, Cleary K, Tapper A, et al. (2011). Pericyte-mediated vasoconstriction underlies TBI-induced hypoperfusion. Neurol Res 33: 176-186.
59. Engelhardt B, Sorokin L, (2009). The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31: 497-511.
60. Fan X, Heijnen CJ, van der Kooij MA, Groenendaal F, Van Bel F, (2009). The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res Rev 62: 99-108.
61. Fandrey J, Gassmann M, (2009). Oxygen sensing and the activation of the hypoxia inducible factor 1 (HIF-1)-invited article. Adv Exp Med Biol 648: 197-206.
62. Fang H, Zhang L-F, Meng F-T, Du X, Zhou J-N, (2010). Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci Lett 474: 173-177.
63. Fazzina G, Amorini AM, Marmarou CR, Fukui S, Okuno K, Dunbar JG, et al. (2010). The protein kinase C activator phorbol myristate acetate decreases brain edema by aquaporin 4 downregulation after middle cerebral artery occlusion in the rat. J Neurotrauma 27: 453-461.
64. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W, Karliczek GF, (1999). Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276: C812-C820.
65. Fischer S, Wobben M, Kleinstuck J, Renz D, Schaper W, (2000). Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells. Am J Physiol Cell Physiol 279: C935-C944.
66. Fischer S, Wobben M, Marti HH, Renz D, Schaper W, (2002). Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63: 70-80.
67. Fleegal MA, Hom S, Borg LK, Davis TP, (2005). Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 289: H2012-H2019.
68. Foglio E, Rodella LF, (2010). Aquaporins and neurodegenerative diseases. Curr Neuropharmacol 8: 112-121.
69. Förster C, (2008). Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 130: 55-70.
70. Fukuda AM, Badaut J, (2012). Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation 9: 279.
71. Fukuda AM, Adami A, Pop V, Bellone JA, Coats JS, Hartman RE, et al. (2013). Posttraumatic reduction of edema with aquaporin-4 RNA interference improves acute and chronic functional recovery. J Cereb Blood Flow Metab 33: 1-12.
72. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston Jr LL, Zoppo G, (2004). Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35: 998-1004.
73. Gaetz M, (2004). The neurophysiology of brain injury. Clin Neurophysiol 115: 4-18.
74. Gassmann M, Heinicke K, Soliz J, Ogunshola OO, (2003). Non-erythroid functions of erythropoietin. Adv Exp Med Biol 543: 323-330.
75. Gonul E, Duz B, Kahraman S, Kayali H, Kubar A, Timurkaynak E, (2002). Early pericyte response to brain hypoxia in cats: an ultrastructural study. Microvasc Res 64: 116-119.
76. Grammas P, (2011). Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 8: 26.
77. Greenberg SM, Gurol ME, Rosand J, Smith EE, (2004). Amyloid angiopathy-related vascular cognitive impairment. Stroke 35: 2616-2619.
78. Greenberger LM, Horak ID, Filpula D, Sapra P, Westergaard M, Frydenlund HF, et al. (2008). A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth. Mol Cancer Ther 7: 3598-3608.
79. Hafny B, Bourre JM, Roux F, (1996). Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J Cell Physiol 167: 451-460.
80. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM, (2005). Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85: 979-1000.
81. Hamann GF, Okada Y, Fitridge R, Zoppo GJ, (1995). Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26: 2120-2126.
82. Hamann GF, Liebetrau M, Martens H, Burggraf D, Kloss CUA, Bültemeier G, et al. (2002). Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 22: 526-533.
83. Harten SK, Ashcroft M, Maxwell PH, (2010). Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection. Antioxid Redox Signal 12: 459-480.
84. Hartmann C, Zozulya A, Wegener J, Galla HJ, (2007). The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. Exp Cell Res 313: 1318-1325.
85. Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ, (2011). Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 199: 223-229.
86. Hawkins BT, Davis TP, (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185.
87. Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, Niwa M, (2004). Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept 123: 77-83.
88. Hayashi T, Kaneko Y, Yu S, Bae E, Stahl CE, Kawase T, et al. (2010). Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res 1280: 177-192.
89. Hayashi Y, Nomura M, Yamagishi S, Harada S, Yamashita J, Yamamoto H, (1997). Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 19: 13-26.
90. Hellewell SC, Yan EB, Agyapomaa DA, Bye N, Morganti-Kossmann MC, (2010). Post-traumatic hypoxia exacerbates brain tissue damage: analysis of axonal injury and glial responses. J Neurotrauma 27: 1997-2010.
91. Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, et al. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
92. Herholz K, (2010). Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev Neurother 10: 1667-1673.
93. Hicks RR, Baldwin SA, Scheff SW, (1997). Serum extravasation and cytoskeletal alterations following traumatic brain injury in rats. Comparison of lateral fluid percussion and cortical impact models. Mol Chem Neuropathol 32: 1-16.
94. Hori S, Ohtsuki S, Hosoya K, Nakashima E, Terasaki T, (2004). A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem 89: 503-513.
95. Hu Y, Liu J, Huang H, (2012). Recent agents targeting HIF-1α for cancer therapy. J Cell Biochem 114: 1-28.
96. Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM, (1999). Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 26: 298-304.
97. Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, et al. (1999). Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun 261: 108-112.
98. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472.
99. Janzer RC, Raff MC, (1987). Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325: 253-257.
100. Jiang X, Namura S, Nagata I, (2001). Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305: 41-44.
101. Jones NM, Kardashyan L, Callaway JK, Lee EM, Beart PM, (2008). Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr Res 63: 620-624.
102. Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S, (2003). Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339: 341-346.
103. Karuppagounder SS, Ratan RR, (2012). Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J Cereb Blood Flow Metab 32: 1347-1361.
104. Kaur C, Sivakumar V, Zhang Y, Ling EA, (2006). Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum. Glia 54: 826-839.
105. Kawahara M, Kuroda Y, Arispe N, Rojas E, (2000). Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275: 14077-14083.
106. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG, (2001). Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21: 372-381.
107. Kim H, Lee JM, Park JS, Jo SA, Kim Y-O, Kim C-W, et al. (2008). Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem Biophys Res Commun 372: 243-248.
108. Kimelberg HK, (2005). Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50: 389-397.
109. Kook S-Y, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I, (2012). Aβ1-42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling. J Neurosci 32: 8845-8854.
110. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, et al. (2007). Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 170: 1389-1397.
111. Krum JM, Mani N, Rosenstein JM, (2008). Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 212: 108-117.
112. Kuhlmann CRW, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, et al. (2007). Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 102: 501-507.
113. Kuroiwa T, Ting P, Martinez H, Klatzo I, (1985). The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol 68: 122-129.
114. Kwon I, Kim EH, Del Zoppo GJ, Heo JH, (2009). Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res 87: 668-676.
115. Ladomery MR, Harper SJ, Bates DO, (2007). Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett 249: 133-142.
116. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, et al. (2003). SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9: 900-906.
117. Lee VM, Goedert M, Trojanowski JQ, (2001). Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-1159.
118. Li L, Zhang X, Yang D, Luo G, Chen S, Le W, (2009). Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging 30: 1091-1098.
119. Li M-M, Wu L-Y, Zhao T, Wu K-W, Xiong L, Zhu L-L, et al. (2011). The protective role of 5-hydroxymethyl-2-furfural (5-HMF) against acute hypobaric hypoxia. Cell Stress Chaperones 16: 529-537.
120. Lindahl P, Johansson BR, Leveen P, Betsholtz C, (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
121. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong C-X, (2008). Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582: 359-364.
122. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, et al. (2010). Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30: 1625-1636.
123. Lu D-YY, Yu W-HH, Yeh W-LL, Tang C-HH, Leung Y-MM, Wong K-LL, et al. (2009). Hypoxia-induced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells. J Cell Physiol 220: 163-173.
124. Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO, (2012). Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9: 23.
125. Majmundar AJ, Wong WJ, Simon MC, (2010). Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309.
126. Mandriota SJ, Pepper MS, (1998). Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83: 852-859.
127. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. (2000). Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-163.
128. Mark KS, Davis TP, (2002). Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282: H1485-H1494.
129. Mayhan WG, (1999). VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276: C1148-C1153.
130. Meijer TWH, Kaanders JHAM, Span PN, Bussink J, (2012). Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18: 5585-5594.
131. Melgar MA, Rafols J, Gloss D, Diaz FG, (2006). Postischemic reperfusion: ultrastructural blood-brain barrier and hemodynamic correlative changes in an awake model of transient forebrain ischemia. Neurosurgery 59: E1152.
132. Mense SM, Sengupta A, Zhou M, Lan C, Bentsman G, Volsky DJ, et al. (2006). Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol Genomics 25: 435-449.
133. Meyer J, Rauh J, Galla HJ, (1991). The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. J Neurochem 57: 1971-1977.
134. Michaelis ML, Dobrowsky RT, Li G, (2002). Tau neurofibrillary pathology and microtubule stability. J Mol Neurosci 19: 289-293.
135. Mizuguchi H, Hashioka Y, Fujii A, Utoguchi N, Kubo K, Nakagawa S, et al. (1994). Glial extracellular matrix modulates gamma-glutamyl transpeptidase activity in cultured bovine brain capillary and bovine aortic endothelial cells. Brain Res 651: 155-159.
136. Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, Zhang W, (2007). Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 4: 12.
137. Morancho A, Rosell A, Garcia-Bonilla L, Montaner J, García-Bonilla L, (2010). Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann N Y Acad Sci 1207: 123-133.
138. Morgan R, Kreipke CW, Roberts G, Bagchi M, Rafols JA, (2007). Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis. Neurol Res 29: 375-381.
139. Nag S, Takahashi JL, Kilty DW, (1997). Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 56: 912-921.
140. Nag S, Kapadia A, Stewart DJ, (2011). Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37: 3-23.
141. Nagel S, Talbot NP, Mecinovic J, Smith TG, Buchan AM, Schofield CJ, (2010). Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal 12: 481-501.
142. Nagy Z, Mathieson G, Hüttner I, (1979). Blood-brain barrier opening to horseradish peroxidase in acute arterial hypertension. Acta Neuropathol 48: 45-53.
143. Nakagawa S, Deli MA, Nakao S, Honda M, Hayashi K, Nakaoke R, et al. (2007). Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 27: 687-694.
144. Nakagawa S, Deli M, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, et al. (2009). A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54: 253-263.
145. Nakayama M, Berger P, (2013). Coordination of VEGF receptor trafficking and signaling by coreceptors. Exp Cell Res 319: 1340-1347.
146. Nalivaevaa NN, Fisk L, Kochkina EG, Plesneva SA, Zhuravin IA, Babusikova E, et al. (2004). Effect of hypoxia/ischemia and hypoxic preconditioning/ reperfusion on expression of some amyloid-degrading enzymes. Ann N Y Acad Sci 1035: 21-33.
147. Nico B, Ribatti D, (2012). Morphofunctional aspects of the blood-brain barrier. Curr Drug Metab 13: 50-60.
148. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP, (1997). Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17: 171-180.
149. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, et al. (2008). Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 121: 3487-3495.
150. Ogunshola OO, (2011). In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des 17: 2755-2761.
151. Ogunshola OO, Al-Ahmad A, (2012). HIF-1 at the blood-brain barrier: a mediator of permeability? High Alt Med Biol 13: 153-161.
152. Ogunshola OO, Antoniou X, (2009). Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration? Cell Mol Life Sci 66: 3555-3563.
153. Osada T, Gu YH, Kanazawa M, Tsubota Y, Hawkins BT, Spatz M, et al. (2011). Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by beta(1)-integrins. J Cereb Blood Flow Metab 31: 1972-1985.
154. Paolinelli R, Corada M, Orsenigo F, Dejana E, (2011). The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol Res 63: 165-171.
155. Papadopoulos MC, Verkman AS, (2007). Aquaporin-4 and brain edema. Pediatr Nephrol 22: 778-784.
156. Papadopoulos MC, Manley GT, Krishna S, Verkman AS, (2004). Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18: 1291-1293.
157. Papavassiliou E, Gogate N, Proescholdt M, Heiss JD, Walbridge S, Edwards NA, et al. (1997). Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res 49: 451-460.
158. Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M, (2004). Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366: 80-85.
159. Park K, Rosell A, Foerch C, Xing C, Kim WJ, Lee S, et al. (2009). Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 40: 2836-2842.
160. Park YS, Kim NH, Jo I, (2003). Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes. Microvasc Res 65: 125-131.
161. Patel HC, Boutin H, Allan SM, (2003). Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. Ann N Y Acad Sci 992: 39-47.
162. Peers C, Dallas ML, Boycott HE, Scragg JL, Pearson H, Boyle JP, (2009). Hypoxia and neurodegeneration. Ann N Y Acad Sci 1177: 169-177.
163. Plate KH, (1999a). Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58: 313-320.
164. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C, (1999b). Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 58: 654-666.
165. Plateel M, Teissier E, Cecchelli R, (1997). Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J Neurochem 68: 874-877.
166. Pluta R, (2007). Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain. Curr Neurovasc Res 4: 121-129.
167. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, et al. (2002). Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22: 520-525.
168. Rascher G, Fischmann A, Kroger S, Duffner F, Grote EH, Wolburg H, (2002). Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol 104: 85-91.
169. Ratan RR, Siddiq A, Smirnova N, Karpisheva K, Haskew-Layton R, McConoughey S, et al. (2007). Harnessing hypoxic adaptation to prevent, treat,
170. Ratan RR, Siddiq A, Aminova L, Langley B, McConoughey S, Karpisheva K, et al. (2008). Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann N Y Acad Sci 1147: 383-394.
171. Raub TJ, Kuentzel SL, Sawada GA, (1992). Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. Exp Cell Res 199: 330-340.
172. Reuss B, Dono R, Unsicker K, (2003). Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J Neurosci 23: 6404-6412.
173. Rist RJ, Romero IA, Chan MW, Couraud PO, Roux F, Abbott NJ, (1997). F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors. Brain Res 768: 10-18.
174. Roberts J, Kahle MP, Bix GJ, (2012). Perlecan and the blood-brain barrier: beneficial proteolysis? Front Pharmacol 3: 155.
175. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC, (1998). Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030.
176. Rosenberg GA, (2009). Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet 8: 205-216.
177. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, et al. (1991). A cell culture model of the blood-brain barrier. J Cell Biol 115: 1725-1735.
178. Sagare AP, Bell RD, Zlokovic BV, (2012). Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2: pii: a011452.
179. Sandoval KE, Witt KA, (2008). Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32: 200-219.
180. Sa-Pereira I, Brites D, Brito MA, Sá-Pereira I, (2012). Neurovascular unit: a focus on pericytes. Mol Neurobiol 45: 327-347.
181. Schmid-Brunclik N, Burgi-Taboada C, Antoniou X, Gassmann M, Ogunshola OO, Bürgi-Taboada C, (2008). Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. Am J Physiol Regul Integr Comp Physiol 295: R864-R873.
182. Schoch HJ, Fischer S, Marti HH, (2002). Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125: 2549-2557.
183. Scholler K, Trinkl A, Klopotowski M, Thal SC, Plesnila N, Trabold R, et al. (2007). Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 1142: 237-246.
184. Schroeter ML, Mertsch K, Giese H, Muller S, Sporbert A, Hickel B, et al. (1999). Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449: 241-244.
185. Selkoe DJ, (2001). Alzheimer's disease?: genes, proteins, and therapy. Perspective 81: 741-767.
186. Semenza GL, (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
187. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC, (2010). Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab 30: 769-782.
188. Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, O'Banion MK, (2007). Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 27: 9301-9309.
189. Shen W, Li S, Chung SH, Zhu L, Stayt J, Su T, et al. (2011). Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-beta1-induced permeability of centrally derived vascular endothelium. Eur J Cell Biol 90: 323-332.
190. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. (2000). Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499.
191. Shigemori Y, Katayama Y, Mori T, Maeda T, Kawamata T, (2006). Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir Suppl 96: 130-133.
192. Shimizu F, Sano Y, Abe MA, Maeda T, Ohtsuki S, Terasaki T, et al. (2011). Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol 226: 255-266.
193. Shimizu F, Sano Y, Saito K, Abe MA, Maeda T, Haruki H, et al. (2012). Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res 37: 401-409.
194. Siddharthan V, Kim YV, Liu S, Kim KS, (2007). Human astrocytes/astrocyte- conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells. Brain Res 1147: 39-50.
195. Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, et al. (2005). Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem 280: 41732-41743.
196. Singh N, Sharma G, Mishra V, Raghubir R, (2012). Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol 32: 491-507.
197. Sköld MK, Gertten CV, Sandberg-Nordqvist A-C, Mathiesen T, Holmin S, (2002). VEGF and VEGF receptor expression after experimental brain contusion in rat. J Neurotrauma 19: 353-367.
198. Smirnova NA, Hushpulian DM, Speer RE, Gaisina IN, Ratan RR, Gazaryan IG, (2012). Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases. Biochemistry 77: 1108-1119.
199. Sobue K, Yamamoto N, Yoneda K, Hodgson ME, Yamashiro K, Tsuruoka N, et al. (1999). Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 35: 155-164.
200. Song HS, Son MJ, Lee YM, Kim WJ, Lee S-W, Kim CW, et al. (2002). Oxygen tension regulates the maturation of the blood-brain barrier. Biochem Biophys Res Commun 290: 325-331.
201. Sorond FA, Ratan RR, (2000). Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2: 421-436.
202. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV, (2003). Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 116: 4615-4628.
203. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Rooijen NV, et al. (2005). Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25: 593-606.
204. Stanimirovic DB, Friedman A, (2012). Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab 32: 1207-1221.
205. Stewart PA, Wiley MJ, (1981). Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev Biol 84: 183-192.
206. Stuart RO, Sun A, Bush KT, Nigam SK, (1996). Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J Biol Chem 271: 13636-13641.
207. Sun M-C, Honey CR, Berk C, Wong NLM, Tsui JKC, (2003). Regulation of aquaporin-4 in a traumatic brain injury model in rats. J Neurosurg 98: 9-20.
208. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. (2006). Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103: 18727-18732.
209. Takata F, Dohgu S, Matsumoto J, Takahashi H, Machida T, Wakigawa T, et al. (2011). Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation 8: 106.
210. Tang Y, Wu P, Su J, Xiang J, Cai D, Dong Q, (2010). Effects of Aquaporin-4 on edema formation following intracerebral hemorrhage. Exp Neurol 223: 485-495.
211. Tao-Cheng JH, Nagy Z, Brightman MW, (1987). Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 7: 3293-3299.
212. Tatsuta T, Naito M, Mikami K, Tsuruo T, (1994). Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differ 5: 1145-1152.
213. Taya K, Gulsen S, Okuno K, Prieto R, Marmarou CR, Marmarou A, (2008). Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema. Acta Neurochir Suppl 102: 425-429.
214. Tejima E, Guo S, Murata Y, Arai K, Lok J, Van Leyen K, et al. (2009). Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J Neurotrauma 26: 1935-1941.
215. Tesseur I, Wyss-Coray T, (2006). A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. Curr Alzheimer Res 3: 505-513.
216. Thanabalasundaram G, Pieper C, Lischper M, Galla H-J, (2010). Regulation of the blood-brain barrier integrity by pericytes via matrix metalloproteinases mediated activation of vascular endothelial growth factor in vitro. Brain Res 1347: 1-10.
217. Thanabalasundaram G, Schneidewind J, Pieper C, Galla H-J, (2011). The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. Int J Biochem Cell Biol 43: 1284-1293.
218. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M, (1996). beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380: 168-171.
219. Tilling T, Korte D, Hoheisel D, Galla HJ, (1998). Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J Neurochem 71: 1151-1157.
220. Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, Dreier JP, et al. (2007). Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25: 367-377.
221. Tomkins O, Shelef I, Kaizerman I, Eliushin A, Afawi Z, Misk A, et al. (2008). Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 79: 774-777.
222. Trendelenburg G, Dirnagl U, (2005). Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50: 307-320.
223. Turner DA, Adamson DC, (2011). Neuronal-astrocyte metabolic interactions. J Neuropathol Exp Neurol 70: 167-176.
224. Unterberg AW, Stover J, Kress B, Kiening KL, (2004). Edema and brain trauma. Neuroscience 129: 1021-1029.
225. Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, et al. (2005). VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab 25: 1491-1504.
226. Vangeison G, Rempe DA, (2009). The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist 15: 579-588.
227. Vangeison G, Carr D, Federoff HJ, Rempe DA, (2008). The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 28: 1988-1993.
228. Vannucci SJ, Maher F, Simpson IA, (1997). Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21: 2-21.
229. Vilalta A, Sahuquillo J, Poca MA, De Los Rios J, Cuadrado E, Ortega-Aznar A, et al. (2008). Brain contusions induce a strong local overexpression of MMP-9. Results of a pilot study. Acta Neurochir Suppl 102: 415-419.
230. Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, et al. (2007). Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K / Akt pathway. J Cell Physiol 212: 236-243.
231. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA, (2009). TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE 4: e5149.
232. Wang CX, Shuaib A, (2002). Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 67: 161-172.
233. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, et al. (2000). Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20: 7037-7042.
234. Wang YL, Hui YN, Guo B, Ma JX, (2007). Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way. Eye 21: 1501-1510.
235. Wenger RH, Stiehl DP, Camenisch G, (2005). Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12.
236. Wilcock DM, Vitek MP, Colton CA, (2009). Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 159: 1055-1069.
237. Willis CL, Nolan CC, Reith SN, Lister T, Prior MJ, Guerin CJ, et al. (2004). Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact. Glia 45: 325-337.
238. Willis CL, Meske DS, Davis TP, (2010). Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab 30: 1847-1859.
239. Witt KA, Mark KS, Sandoval KE, Davis TP, (2008). Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res 75: 91-96.
240. Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P, (2009a). Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335: 75-96.
241. Wolburg H, Noell S, Wolburg-Buchholz K, Mack A, Fallier-Becker P, (2009b). Agrin, aquaporin-4, and astrocyte polarity as an important feature of the blood-brain barrier. Neuroscientist 15: 180-193.
242. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, et al. (2005). Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 11: 959-965.
243. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, et al. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7: 612-618.
244. Xia Y, Choi H-K, Lee K, (2012). Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem 49C: 24-40.
245. Yamagata K, Tagami M, Takenaga F, Yamori Y, Itoh S, (2004). Hypoxia-induced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol Dis 17: 491-499.
246. Yang S-P, Bae D-G, Kang HJ, Gwag BJ, Gho YS, Chae C-B, (2004). Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 25: 283-290.
247. Yeh W-L, Lu D-Y, Lin C-J, Liou H-C, Fu W-M, (2007). Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 72: 440-449.
248. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T, (2009). Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15: 1031-1037.
249. Zehendner CM, Librizzi L, de Curtis M, Kuhlmann CR, Luhmann HJ, (2011). Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS ONE 6: e16760.
250. Zeng XN, Xie LL, Liang R, Sun XL, Fan Y, Hu G, (2012). AQP4 knockout aggravates ischemia/reperfusion injury in mice. CNS Neurosci Ther 18: 388-394.
251. Zhang W, Petrovic JM, Callaghan D, Jones A, Cui H, Howlett C, et al. (2006). Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J Neuroimmunol 174: 63-73.
252. Zhang X, Cheng M, Chintala SK, (2004). Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci Lett 356: 140-144.
253. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao F-F, et al. (2007). Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282: 10873-10880.
254. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al. (2000). VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838.
255. Zhang ZG, Zhang L, Croll SD, Chopp M, (2002). Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 113: 683-687.
256. Zhao B-QQ, Wang S, Kim H-YY, Storrie H, Rosen BR, Mooney DJ, et al. (2006). Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12: 441-445.
257. Zhou L, Chan KH, Chu LW, Kwan JSC, Song YQ, Chen LH, et al. (2012). Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis. Biochem Biophys Res 423: 697-702.
258. Zlokovic BV, (2005). Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28: 202-208.
259. Zlokovic BV, (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-738.
260. Del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, et al. (2007). Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 38: 646-651.
261. Zozulya A, Weidenfeller C, Galla HJ, (2008). Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res 1189: 1-11.